Dianthus Therapeutics 320% Year: What Investors Should Know as Stakes Shift
Dianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Identify index funds with top risk-adjusted returns to guide smarter allocations. Learn criteria for selecting high-efficiency funds.
28,465 articlesDianthus Therapeutics has surged 320% over the past year, even as a large investor reduced its stake. This article di...
Ben Chester navigated a path from crushing debt renting to a thriving landlord with eight properties, three short-ter...
The SEC has moved to clarify which crypto assets fall under securities rules, saying that many assets—including staki...
A fresh partnership announcement sent nano nuclear energy stock higher as investors weigh the promise of small modula...
Investors are buzzing about QuantumScape after news of a major automaker collaboration. This article breaks down what...
A new line of thinking from Google DeepMind suggests AI consciousness debates may spill into policy and crypto govern...
A high-profile security breach at NBC’s Today show sparked questions about accountability and cost. This article brea...
Retirement planning isn’t only about investments. Health coverage decisions during the March window can affect your c...
As XRP hovers in the low-dollar range, investors ask how many tokens would be needed to reach $1 million. The answer ...
Today’s market moves show a tech-led rotation and Meta’s cloud pivot stealing the spotlight. Here’s what it means for...
Archer Aviation teams with defense innovator Anduril to roll out a new autonomous VTOL platform, blending commercial ...
A dramatic 72% decline in a key internet infrastructure stock drew a bold $12 million investment. This article explai...